Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Accuray Inc.

Start price
Target price
Perf. (%)
€3.10
29.04.23
-
29.04.24
-33.55%
30.04.24

StockNews.com 
29.04.23 50%
buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.41
29.04.23
-
29.04.24
10.78%
30.04.24

StockNews.com 
29.04.23 50%
buy
Gaia Inc. A

Start price
Target price
Perf. (%)
€2.70
29.04.23
-
29.04.24
40.74%
30.04.24

StockNews.com 
29.04.23 50%
sell
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.33
29.04.23
-
29.04.24
-3.07%
30.04.24

StockNews.com 
29.04.23 50%
buy
Liquidity Services

Start price
Target price
Perf. (%)
€11.70
29.04.23
-
29.04.24
37.61%
30.04.24

StockNews.com 
29.04.23 50%
sell
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€2.66
29.04.23
-
29.04.24
-88.01%
30.04.24

StockNews.com 
29.04.23 50%
sell
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€0.066
29.04.23
-
29.04.24
148.41%
30.04.24

StockNews.com 
29.04.23 50%
buy
Mammoth Energy Services Inc

Start price
Target price
Perf. (%)
€3.28
29.04.23
-
29.04.24
-9.76%
30.04.24

StockNews.com 
29.04.23 50%
buy
Vallourec S.A.

Start price
Target price
Perf. (%)
€10.15
29.04.23
€20.00
29.04.24
64.61%
30.04.24

Could be worthwhile Investment >10% per year
melinda 
29.04.23 10%
buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€79.50
29.04.23
€97.00
29.04.24
8.81%
30.04.24

Could be worthwhile Investment >10% per year
melinda 
29.04.23 20%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€83.00
03.03.24
€180.00
31.05.26
-16.27%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
03.03.24 70%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€2.30
29.10.23
€4.00
30.06.26
247.39%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.10.23 50%
buy
Travelzoo Inc.

Start price
Target price
Perf. (%)
€6.80
28.04.23
€16.35
28.04.24
16.91%
29.04.24

Barrington Research 
28.04.23 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.91
28.06.23
€7.00
31.01.26
-20.20%
28.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
28.06.23 70%
buy
Microstrateg.a New

Start price
Target price
Perf. (%)
€288.50
27.04.23
-
27.04.24
305.20%
28.04.24

Berenberg Bank 
27.04.23 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.91
08.04.24
€3.00
08.04.25
-21.66%
27.04.24

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Traumtanz 
08.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
buy
All For One Steeb AG

Start price
Target price
Perf. (%)
€40.80
27.04.23
-
27.04.24
47.06%
27.04.24

Erntehelfer 
27.04.23 50%
buy
Bionxt Solutions Inc.

Start price
Target price
Perf. (%)
€0.49
26.04.23
€0.60
26.04.24
-46.61%
27.04.24

Could be worthwhile Investment >10% per year
melinda 
26.04.23 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-8.41%
27.04.24

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
skatcup 
23.04.24 80%
sell
Delticom AG

Start price
Target price
Perf. (%)
€2.06
15.04.24
-
15.04.25
22.33%
27.04.24

High valuation
Probably not worthwhile Investment
Low dividend yield expected
negative Cash Flow expected
kostojunior 
15.04.24 0%
sell
Fair Value Reit-Ag

Start price
Target price
Perf. (%)
€3.66
15.04.24
-
15.04.25
2.73%
27.04.24

Medium risks for its business
negative Cash Flow expected
EBIT decline/stagnation expected
Increased challenges to pay loans and raise capital
kostojunior 
15.04.24 0%
buy
Alba SE

Start price
Target price
Perf. (%)
€10.50
15.04.24
€15.00
15.04.25
-4.76%
27.04.24

Revenue growth >5% per year expected
Future proof or reliable business model
EBIT growth >5% per year expected
Top 10 in its market
kostojunior 
15.04.24 60%
sell
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€13.78
13.04.24
€12.00
13.04.25
-18.00%
27.04.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
nvestor 
13.04.24 50%